Oncimmune
Oncimmune, a global leader in immunodiagnostics is focused on autoantibody biomarker profiling in immuno-oncology, autoimmune and infectious diseases. Through ImmunoINSIGHTS™ technology platform, we provide novel immune biomarker signatures to improve response and adverse event (irAE) prediction, patient screening and diagnostic accuracy.
We are headquartered in the UK with additional operations in Germany and the USA.